EUVIMEDEUVIMED entdecken
Crossref

Tirzepatide as compared with semaglutide for the treatment of obesity

Aronne LJ, Horn DB, CW le Roux, Ho W, Falcon BL, E Gomez Valderas, Das S, Lee CJ, Glass LC, Senyucel C, Dunn JP, Investigators ST

Yearbook of Paediatric Endocrinology · 30.09.2025

DOI: 10.1530/ey.22.15.10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Aronne LJ und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

LJ, A., DB, H., Roux, C. L., W, H., BL, F., Valderas, E. G., S, D., CJ, L., LC, G., C, S., JP, D., & ST, I. (2025). Tirzepatide as compared with semaglutide for the treatment of obesity. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.15.10

Vancouver

LJ A, DB H, Roux CL, W H, BL F, Valderas EG, et al. Tirzepatide as compared with semaglutide for the treatment of obesity. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.15.10

BibTeX
@article{LJ2025,
  author = {LJ, Aronne and DB, Horn and Roux, CW le and W, Ho and BL, Falcon and Valderas, E Gomez and S, Das and CJ, Lee and LC, Glass and C, Senyucel and JP, Dunn and ST, Investigators},
  title = {Tirzepatide as compared with semaglutide for the treatment of obesity},
  journal = {Yearbook of Paediatric Endocrinology},
  year = {2025},
  doi = {10.1530/ey.22.15.10}
}
Kostenlos starten →